NCT03894254 · RECRUITING

Predictive Factors of Autonomy Loss in Real-life Cohort

This French observational study is not testing a drug or treatment. It is building a long-term database of about 5,400 patients with Alzheimer's disease or related memory disorders, tracking them for up to 10 years to identify which factors predict loss of independence over time. There is no intervention — researchers are watching, measuring, and learning. This is a real-world data collection effort, not a clinical trial in the traditional sense.

You may qualify if

  • Patients aged 18 years and older, undergoing a medical visit in a memory center or neuro-cognition service
  • Patients living at home or in housing
  • Patients with memory impairment, at all stage of the disease

You're excluded if

  • Patients in institution
  • Patients under legal protection
  • Patients with a hearing or visual impairment, which prevents carrying out examinations

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2022-05-02

View full record on ClinicalTrials.gov

All APOE4 clinical trials